Abstract
Impairment of vision in diabetes has been suggested to be due to an acceleration of the polyol pathway in the lens as well as in the retina. This acceleration is attributed largely to the rate-limiting steps of glycolysis and consequent diversion of glucose in the polyol pathway with its consequent effects on diverse tissue transport and redox activities. In addition, high sugar also induces a generalized oxidative stress via generating superoxide and its derivatization to other reactive oxygen species (ROS). While the immediate toxicity of hyperglycemia could be linked to the acceleration of this pathway, we hypothesize that in the long term, the toxic effects of the high sugar level are due to an upregulation of certain microRNAs (as we have shown before) and consequent repression of the transcription and translation of many antioxidant and anti-apoptotic genes. Therefore, in the present study, we measured the expression levels of certain major antioxidant and pro- and anti-apoptotic mRNAs in the lenses of mice made hyperglycemic by feeding a high galactose diet, without or with fortification with 1 % sodium pyruvate-a potent ROS scavenger. As speculated, the expression of several antioxidant and anti-apoptotic mRNAs has been found to be significantly repressed in the lenses of animals fed a high galactose diet. Such repression was significantly prevented by pyruvate. Thus, the findings also strongly suggest that visual impairment induced by the diabetic hyperglycemia could be treatable by administration of certain anti-microRNAs.
Similar content being viewed by others
References
Eederer F, Hiller R, Taylor HR (1981) Senile lens changes in two population studies. Am J Ophthalmol 91:381–395
Neilson NV, Vending T (1984) Prevalence of cataracts in insulin dependent and noninsulin dependent diabetes mellitus. Acta Ophthalmol 62:595–602
Klein BEK, Klein R, Moss SE (1985) Prevalence of cataracts in a population based study of persons with diabetes mellitus. Ophthalmology 92:1191–1196
Row N, Mitchel P, Cumming R, Wans JJ (2000) Diabetes, fasting blood glucose and age related cataracts. The blue mountain eye study. Ophthalmic Epidemiol 7:103–114
Bensen WE (1992) Cataract surgery and diabetic retinopathy. Curr Opin Ophthalmol 3:396–400
McCarty CA, Mukesh BN, Fu CL, Taylor HR (1999) Epidemiology of cataract in Australia. Am J Ophthalmolol 128:446–465
Chaikoff IL, Lachman GS (1933) Occurrence of cataracts in experimental pancreatic diabetes. Proc Soc Exp Biol Med 31:237–241
Von-Sallmann L, Caravaggio L, P Grimes, Collins EM (1958) Morphological study on alloxan-induced cataract. Arch Ophthalmol 59:55–67
Kok-Van Alphen CC, Cohen EM (1950) The occurrence of cataract in alloxan diabetic rats. Acta Physiol Pharmacol Neerl 1:400–407
Patterson JW (1951) Development of diabetic cataracts. Am J Ophthalmol 165:61–65
Varma SD, Kinoshita JH (1974) Sorbitol pathway in diabetic and galactosemic rat lens. Biochim Biophys Acta 338:632–640
Patterson JW (1953) Effect of lowered blood sugar on the development of diabetic cataracts. Am J Physiol 172:77–82
Patterson JW (1954) Effect of partial starvation on development of diabetic cataract. Proc Soc Exp Biol Med 87:395
UK Prospective Diabetic Study Group (1998) Effect of intensive blood glucose control with metformin on the complications of over-weight patients with type 2 diabetes. Lancet 352:654–865
Diabetes control and complication trial research Group (DCCT) (1993) The effect of intensive treatment of diabetic on the development and progression of long term complication of insulin dependent diabetes mellitus. N Engl J Med 329:986–997
Epidemiology of diabetes intervention and complication study research group (EDIC) (2005) Intensive diabetes treatment and cardiovascular disease in patients with Type 1 diabetes. N Engl J Med 353:2643–2653
Genuth S (1995) A case for blood glucose control. Adv Intern Med 40:573–623
Mitchell HS, Dodge WMI (1935) Cataract in rats fed on high lactose rations. J Nutr 9:37–49
Kinoshita JH, Merola LO, Dikmak E (1962) The accumulation of dulcitol and water in rabbit lens incubated with galactose. Biochim Biophys Acta 62:176–178
Dische Z, Borenfund E, Zelmenis G (1956) Proteins and protein synthesis in Rat lenses with galactose cataract. Arch Ophthalmol 55:633–642
Frank RN, Kern RJ, Kennedy RA, Frank KW (1983) Galactose induced retinal basement membrane thickening. Prevention by sorbinil. Invest Ophthalmol Vis Sci 24:1519–1524
Engerman RL, Kern TS (1984) Experimental galactosemia produced diabetic like retinopathy. Diabetes 33:97–100
Kador PF, Takahashi Y, Wyman M, Ferris F III (1995) Diabetes like peripheral retinal changes in galactose fed dogs. Arch Ophthalmol 113:352–354
Kowluru RA, Kern TS, Engerman RL, Armstrong D (1996) Abnormalities of retinal metabolism in diabetes or experimental galactosemia III. Effects of antioxidants. Diabetes 45:1233–1237
Kowluru RA (2005) Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal 7:1581–1587
Kowluru RN, Tang J, Kern TS (2001) Abnormalities of retinal metabolism in diabetes and experimental galactosemia VII. Effect of long term administration of antioxidants on the development of diabetic retinopathy. Diabetes 50:1938–1942
Kennedy A, Frank RN, Varma SD (1983) Aldose reductase activity in retinal and cerebral micro vessels and cultured vascular cells. Invest Ophthalmol Vis Sci 24:1250–1258
Kador PF, Akagi Y, Terubayashi H, Wyman M, Kinoshita JH (1988) Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol 106:1099–1102
Chalk C, Benstead TJ, Moore F (2007) Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database Syst Rev. doi:10.1002/14651858.CD004572 (Article No: CD004572)
O’Hare JP, Morgan MH, Alden P, Chissel S, O’Brien ADR, Corrall JM (1988) Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year’s treatment with sorbinil. Diabet Med 5:537–542
NEI Clinical Study (1990) A randomized trial of sorbinil, an aldose reductase inhibitor in diabetic retinopathy. Arch Ophthalmol 108:1234–1244
Varma SD, Hegde KR, Henein M (2003) Oxidative damage to mouse lens in culture. Protective effect of pyruvate. Biochim Biophys Acta 1621:246–252
Hegde KR, Varma SD (2004) Morphogenetic and apoptotic changes in diabetic cataract. Prevention by pyruvate. Mol Cell Biochem 262:233–237
Hegde KR, Varma SD (2005) Prevention of cataract by pyruvate in diabetic mice. Mol Cell Biochem 269:115–120
Varma SD, Hegde KR, Kovtun S (2005) Attenuation and delay of diabetic cataracts by antioxidants. Effectiveness of pyruvate after onset of cataract. Ophthalmologica 219:309–315
Hegde KR, Varma SD (2004) Protective effect of ascorbate against oxidative stress in the mouse lens. Biochim Biophys Acta 1670:12–18
Hegde KR, Varma SD (2008) Oxidative stress to retina. Prevention by pyruvate. Ophthalmologica 222:294–298
Hegde KR, Kovtun S, Varma SD (2010) Inhibition of glycolysis in retina by oxidative stress. Prevention by pyruvate. Mol Cell Biochem 343:101–105
Monnier VM, Cerami A (1982) Non-enzymatic glycosylation and browning in diabetes and aging. Studies on lens proteins. Diabetes 31(3):57–63
Kondo R, Kahn R (2004) Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem 279:37997–38006
Nagaraj RH, Monnier VM (1992) Isolation and characterization of a blue fluorophore from human eye lens crystallins: in vitro formation from Mallard reaction with ascorbate and ribose. Biochim Biophys Acta 5(1116):34–42
Chellan P, Nagaraj RH (1999) Protein crosslinking by the Maillard reaction: di-carbonyl-derived imidazolium crosslinks in aging and diabetes. Arch Biochem Biophys 368:98–104
Shamsi FA, Lin K, Sady C, Nagaraj RH (1998) Methylglyoxal derived modification in lens aging and cataract formation. Invest Ophthalmol Vis Sci 39:2355–2364
Richardson HB (1925) The capacity to oxidize carbohydrate as determined by the respiratory quotient. Phys Biol Chem Exp Pharmakol 24:588–593
Nakaya Y, Ohnaka M, Sakamoto S, Niwa Y, Okada K, Normura M, Hara T, Kusonki M (1998) Respiratory quotient in patients with noninsulin dependent diabetes mellitus treated with insulin and oral hypoglycemic agents. Ann Nutr 42:330–340
dos Santos KC, Pereira Braga C, Octavio Barbanera P, Ferreira Seiva FR, Fernandes Junior A et al (2014) Cardiac Energy Metabolism and Oxidative Stress Biomarkers in Diabetic Rat Treated with Resveratrol. PLoS One 9:e102775
Hegde KR, Varma SD (2009) Electron impact mass spectroscopic studies on mouse retinal fatty acids. Ophthalmic Res 42:9–14
Terry TL (1942) Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens I. Preliminary report. Am J Ophthalmol 25:203–204
Schocket SS, Esterson J, Bradford B, Michaelis M, Richards RD (1972) Induction of cataracts in mice by exposure to oxygen. Isr J Med Sci 8:1596–1601
Palmquist B-M, Philipson BO, Barr P-O (1984) Nuclear cataract and myopia during hyperbaric oxygen therapy. Br J Ophthalmol 68:113–117
Varma SD, Ets TK, Richards RD (1977) Protection against superoxide radicals in rat lens. Ophthalmic Res 9:421–443
Varma SD, Kumar S, Richards RD (1979) Light-induced damage to ocular lens cation pump: prevention by vitamin C. Proc Natl Acad Sci 76:3504–3506
Varma SD, Chand D, Sharma YR, Kuck JF, Richards RD (1984) Oxidative stress on lens and cataract formation: role of light and oxygen. Curr Eye Res 3:35–57
Pande J, Hanlon E, Pande A (2002) A comparison of the environment of thiol groups in bovine and human gamma crystallins using Raman spectroscopy. Exp Eye Res 75:359–363
Babizhayev MA, Deyev AI, Linberg LF (1988) Lipid peroxidation as a possible cause of cataract. Mech Ageing Dev 44:69–89
Lou MF, Dickerson JE (1955) Protein thiol mixed disulfide oxidation in human lens. Exp Eye Res 2:889–896
Phil Clark JI (2013) Self-assembly of protein aggregates in ageing disorders: the lens and cataract model. Trans R Soc B 368:20120104
Varma SD et al (1977) Diabetic cataracts and flavonoids. Science 195:205–206
Roberson JM, Donner AP, Trevithick JR (1991) A possible role of vitamins C and E in cataract prevention. Am J Clin Nutr 53:346S–351S
Varma SD (1991) Scientific basis for medical therapy of cataracts by antioxidants. Am J Clin Nutr 53:335S–345S
Vinison JA, Courey JM, Maro NP (1992) Comparison of two forms of vitamin C on galactose cataracts. Nutr Res 12:915–922
Devamanoharan PS, Farrell R, Varma SD (1995) Levels of SOD mRNA in rat lens: effect of aging. Mol Cell Biochem 152:175–178
Hulsmans M, Keyzer DD, Holvoet P (2011) MicroRNA regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J 25:2515–2527
Vandesompele J, De Perter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 18:1–12
Varma SD, Kovtun S, Hegde K, Yin J, Ramanath J (2012) Effect of high sugar levels on miRNA expression. Studies with galactosemic mice lenses. Mol Vis 18:1609–1618
Varma SD, Kovtun S (2013) Protective effect of caffeine against high sugar induced transcription of microRNAs and consequent gene silencing: a study of galactosemic mice. Mol Vis 19:493–500
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116:281–297
Ambrose V (2004) The functions of microRNAs. Nature 431:350–355
Chang TC, Mendel JT (2007) MicroRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 8:215–239
Wang Z, Liu Y, Han N, Chen X, Yu W, Zhang W, Zou F (2010) Profiles of oxidative stress—related microRNA and mRNA expression in auditory cells. Brain Res 1346:14–25
Sangokoya C, Telen MJ, Chi JT (2010) MicroRNA mir-144 modulated oxidative stress tolerance and associated with anemia severity in sickle cell disease. Blood 116:4338–4348
Kantorow M, Hawse JR, Colwell TL, Behaved S, Ouzzrri GO, Reddy VN, Hejtmancik JF (2004) Methionine sulfide reductase A is important for lens cell viability and resistance to oxidative stress. Proc Natl Acad Sci 101:9654–9659
Suh JK, Lawrence L, Poulsen LL, Ziegler DM, Robertus JD (1999) Yeast flavin-containing monooxygenase generates oxidizing equivalents that control protein folding in the endoplasmic reticulum. Proc Natl Acad Sci USA 96:2687–2691
Henderson MC, Krueger SK, Stevens JF, Williams DE (2004) Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thiourea and oxidation of glutathione. Chem Res Toxicol 17:633–640
Zhao W, Devamanoharan PS, Henein M, Ali AH, Varma SD (2000) Diabetes-induced biochemical changes in rat lens: attenuation of cataractogenesis by pyruvate. Diabetes Obes Metab 2(3):165–174
Kalakonda S, Hegde KR, Varma SD (2004) Induction of apoptosis in galactosemic lenses. Prevention by Pyruvate. Poster presentation. Association for Research in Vision and Ophthalmology, Fort Lauderdale
Jovanovic M, Hengartner MO (2006) miRNAs and apoptosis: RNAs to die for. Oncogene 25:6176–6187
van Rooij E, Purcell A, Levin AA (2012) Developing microRNA therapeutics. Circ Res 110:483–495
Acknowledgments
We highly thank QIAGEN Genomic Services for many discussions and supplies. Technical assistance was kindly provided by Kayla Vondy. Funding source. NIH-NEI.-01292.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Varma, S.D., Chandrasekaran, K. High sugar-induced repression of antioxidant and anti-apoptotic genes in lens: Reversal by pyruvate. Mol Cell Biochem 403, 149–158 (2015). https://doi.org/10.1007/s11010-015-2345-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-015-2345-y